Katrin Jack is currently the Global Access Strategy Head at Galderma, having previously led global market access for Nemolizumab. With extensive experience in market access and pricing strategy from roles at Takeda and PriceSpective LLC, Katrin has contributed to over 20 healthcare projects. Additionally, they served as the President of the Zurich-Zug Chapter of the Healthcare Businesswomen’s Association from 2021 to 2022. Katrin holds a BSc in Biomedical Informatics and a Master’s in International Health Care Management, further enhanced by strategic leadership training from Saïd Business School, University of Oxford.
This person is not in the org chart
This person is not in any teams
This person is not in any offices